Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 551 - 600 out of 7,614

Document Document Title
WO/2012/040138A2
Novel radiotracer(s) for Positron Emission Tomography (PET) or Single Photon Emission Computed Tomography (SPECT) imaging of disease states related to altered choline metabolism (e.g., tumor imaging of prostate, breast, brain, esophageal...  
WO/2012/038974A1
Provided is a process for the preparing l-phenyl-3-dimethylaminopropane derivatives of formula I, (The formula should be inserted here) and its pharmaceutically acceptable salts thereof via novel intermediates.  
WO/2012/029794A1
The present invention provides an aromatic compound containing a specific branch. This aromatic compound containing a specific branch is easily soluble in isopropyl acetate, which is excellent for separating liquids, and can be used for ...  
WO/2012/028323A1
Described is a process for the preparation of halogenated 4,4'-methylene-bis- anilines by a direct halogenation of 4,4'-methylene-bis-anilines. High yields and a flexible control of the grade of halogenation at the aromatic rings can be ...  
WO/2012/023546A1
The purpose of the present invention is to provide a process by which hydrogen or heavy hydrogens can be easily produced without using large-scale equipment and a process by which hydrogenation (protiation, deuteration or tritiation) can...  
WO/2012/020418A1
The present invention relates to novel polymorphs of 4-hydroxy Atomoxetine hydrochloride and process for the preparation thereof. The present invention also relates to crystalline monohydrate and anhydrate forms of 4-hydroxy Atomoxetine ...  
WO/2012/020742A1
Disclosed is a novel compound that acts as an antagonist for P2X3 and/or P2X2/3 receptors. Also disclosed is a pharmaceutical composition that acts as an antagonist for P2X3 and/or P2X2/3 receptors, said composition containing: a compoun...  
WO/2012/013691A1
Biphenyl diol compounds of formula (I) and their use as a medicament to suppress tumor growth and/or prevent recurrence or metastasis or to treat a cancer selected from the group consisting of brain, bone, colon, ovary, pancreas, prostat...  
WO/2012/009472A2
The present disclosure provides novel oligo phenylene ethynylene (OPE) compounds, methods for synthesizing these compounds, and materials and substances incorporating these compounds. The various OPEs show antibacterial, antiviral and an...  
WO/2012/005693A1
The present invention relates to a method for the synthesis of an α amino acetal, comprising (i) oxidizing a tertiary amine in the presence of a copper catalyst, at least one oxidant and a solvent, or (ii) reacting a secondary amine and...  
WO/2012/002465A1
Disclosed are: a material for a liquid crystal alignment film, which does not undergo film detachment or scratching during rubbing even when the material is burned at a temperature of 200˚C or lower and can achieve good liquid crystal a...  
WO/2012/001571A1
The object of the present invention is a new process for the synthesis of tapentadol, both as free base and in hydrochloride form, which comprises the step of alkylation of the ketone (VII) to yield the compound (VIII), as reported in Di...  
WO/2012/000498A1
The present invention relates to the crystalline, polymorphic Form C of the calcimimetic compound {4-[(1R,3S)-3-((R)-1-Naphthalen-1-yl-ethylamino)-cyclopentyl ]-phenoxy}-acetic acid, to methods of preparation thereof, to methods of chara...  
WO/2012/000499A1
The present invention relates to the crystalline, polymorphic Form X of the calcimimetic compound {4-[(1R, 3S)-3-((R)-1 -Naphthalen-1 -yl-ethylamino)-cyclopentyl]-phenoxy}-acetic acid, to methods of preparation thereof, to methods of cha...  
WO/2011/157390A2
The present invention relates to a process for the preparation of substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds.  
WO/2011/158959A1
Disclosed is a process for producing an intermediate for a cyclic carbodiimide compound. Specifically disclosed are: a process for producing an amine compound represented by formula (B), which involves a step of reducing a nitro compound...  
WO/2011/154140A2
A novel process for the preparation of N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, also known as agomelatine, Compound (I), from 7-methoxy-tetralone as starting material, and to a new crystalline form X of agomelatine.  
WO/2011/147576A1
The present invention relates to a process for the preparation of substituted 1-aminomethyl-2-phenyl-cyclohexane compounds.  
WO/2011/145019A1
The present invention relates to an improved process for the preparation of biologically active diphenylpropylamine derivatives. The present invention specifically relates to an improved fesoterodine of formula (I) and its pharmaceutical...  
WO/2011/144651A1
The invention relates to a method for producing 2-(2-tert.-butylamino-ethoxy)-ethanol (tert.-butylaminodiglycol, TBADG) by reacting diethylene glycol (DG) with tert.-butylamine (TBA) in the presence of hydrogen and a copper-containing ca...  
WO/2011/141705A1
The present invention provides compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel cationic lipids and nucleic acid-lipid particles that provide efficient encapsulation of nucleic ...  
WO/2011/141704A1
The present invention provides compositions and methods for the delivery of therapeutic agents to cells. In particular, these include novel cationic lipids and nucleic acid- lipid particles that provide efficient encapsulation of nucleic...  
WO/2011/136368A1
Disclosed is a cationic lipid which is represented by formula (I) and makes it easier to introduce a nucleic acid into a cell. (In formula (I), R1 and R2 may be the same or different and each represents an alkenyl group or the like; X1 a...  
WO/2011/136369A1
Disclosed is a cationic lipid which is represented by formula (I) and makes it easier to introduce a nucleic acid into a cell. (In formula (I), R1 and R2 may be the same or different and each represents a (Z)-pentadekenyl group, a (Z)-he...  
WO/2011/131697A1
The present invention relates to a compound of Formula 1, wherein: (A) is heteroaryl or aryl; each (Α'), if present, is independently chosen from aryl, arylalkoxy, arylalkyl, heterocyclyl, aryloxy, halo, alkoxy, haloalkyl, cycloalkyl, h...  
WO/2011/130194A2
Provided here are methods of manufacture of viloxazine and its various salts, as well as viloxazine-related compounds, such as novel intermediate reaction products and polymorphs thereof. In particular, the methods provide a substantiall...  
WO/2011/107705A1
The present invention relates to ketobenzofuran derivatives of the general formula (D) shown below, as well as to a method for synthesising same by coupling a quinonimine and an enaminone by a Nenitzescu reaction and to the intermediates...  
WO/2011/105576A1
Disclosed are: a liquid crystal aligning agent which is capable of providing a liquid crystal alignment film that has high rubbing resistance, good liquid crystal aligning properties and high voltage holding ratio; a polymer for the liqu...  
WO/2011/105088A1
Disclosed is a novel diamine compound, shown in equation (1). In equation (1), A represents an aromatic group (number of rings 4 or less) or a divalent aliphatic group (carbon number 10 or less) with an optional substituent. The disclose...  
WO/2011/097336A2
Highly selective 5-HT(2C) receptor agonists receptors are disclosed. The 5-HT(2C) receptor agonists are used in the treatments of disease and conditions wherein modulation of 5-HT(2C) receptors provides a benefit, such as obesity and psy...  
WO/2011/086115A2
The invention relates to a compound comprising a pesticide and an alkoxylate. The invention further relates to the alkoxylate, to a method for the production thereof, and to the use thereof as an auxiliary agent in pesticide-containing s...  
WO/2011/085454A1
The present invention provides for novel benzene compounds and saccharide compounds and for the use of said compounds for binding, titration (quantification), removing, purifying or separating the glycoprotein gp120, gp120 comprising vir...  
WO/2011/084810A2
New triaminophenol compositions and related compounds are disclosed, as are processes for their preparation and for the preparation of novel salts and diacid complexes from such compounds. Polymers prepared from these compositions can be...  
WO/2011/079439A1
The present invention relates to a kind of novel carbene ligands and corresponding new ruthenium catalysts, which are highly active and selective for ROMP and RCM reactions. It discloses the significant electronic effect of different sub...  
WO/2011/078295A1
Provided is a protecting reagent which can undergo deprotection in high yield even under acidic conditions in organic syntheses, e.g., peptide synthesis, and which enables high-purity products to be obtained. The protecting reagent is a ...  
WO/2011/076708A1
The present application relates to compounds of formula (I): and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are as defined herein, compositions containing such compounds and the uses of such compound...  
WO/2011/068209A1
Disclosed are: a composition containing an intermediate for a water-soluble monomer, which can be used suitably for the production of a water-soluble poly(alkylene glycol) monomer that has a polymerizable double bond at the terminal, can...  
WO/2011/068987A2
Methods of treating exposure to Giardia lamblia and/or giardiasis and methods of antagonizing Giardia lamblia attachment to the intestinal wall of a subject are described herein.  
WO/2011/065420A1
Provided is a novel method for manufacturing a 6-substituted-1-methyl-1H-benzimidazole derivative. Also provided is a manufacturing intermediate from said method. The provided method, which manufactures a 6-substituted-1-methyl-1H-benzim...  
WO/2011/065530A1
Disclosed is an organic luminous element, in which an organic layer can be formed by coating and which has a long service life. Specifically disclosed is an organic luminous element which comprises a pair of electrodes and an organic com...  
WO/2011/058572A2
The present invention provides racemic dapoxetine solid, process for its preparation and pharmaceutical compositions comprising it. The present invention also provides S-enantiomer of dapoxetine solid, process for its preparation and pha...  
WO/2011/056448A1
Provided are new functionalized surfactants and methods of their preparation and use. The surfactants are compounds of formula I: wherein R1, R2, and R3 are as defined herein.  
WO/2011/056620A1
Cationic surfactants of formula I in which R1, R2, R3, R4, R5, R6, X and n are as defined are useful in a variety of applications, including in cleaners, detergents and personal care products, particularly shampoos and conditioners.  
WO/2011/054805A1
Certain novel substituted 3-(phenoxymethyl) benzyl amines and personal care compositions comprising such, which are particularly beneficial for skin lightening and achieving evenness of color, especially for face and underarm skin.  
WO/2011/051853A1
The invention describes a novel technical process and novel intermediates useful for the manufacture of enantiomerically pure 8- aryloctanoic acids of the formula (I) which are pharmaceutically active compounds as rennin inhibitors.  
WO/2011/053706A1
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows: wherein R1, R2, R3, Ra, and Y are defined herein.  
WO/2011/042288A1
The present invention relates to a material including a (poly)glycerol group and a hydrophobic group connected together by a heteroatom, to a method for synthesizing same, and to the use thereof as a surfactant. The present invention als...  
WO/2011/041529A2
The invention relates to tri-2-naphthylamines that can be useful in a variety of optical devices as hole-transport materials. For example, the tri-2-naphthylamines can be useful as hole-transport materials in organic light emitting diodes.  
WO/2011/032476A1
A method for preparing levo-betaxolol hydrochloride is provided. The method includes using p-hydroxyl phenyl ethanol as starting material and obtaining the pure levo-betaxolol hydrochloride by selectively esterifying alcoholic hydroxyl, ...  
WO/2011/029614A1
The present invention relates to crystalline modifications of (1R,3R,6R)-6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cycloh exane-1,3-diol, (1S,3S,6S)-6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cycloh exane-1,3-diol and mixtures thereof, ...  

Matches 551 - 600 out of 7,614